Aug 2, 20221 min readMonoclonal antibody treatment for malaria shows encouraging resultsOnly two of 17 participants in the Phase 1 clinical trial contracted malaria after being given the monoclonal antibody treatment, known as L9LS.
Only two of 17 participants in the Phase 1 clinical trial contracted malaria after being given the monoclonal antibody treatment, known as L9LS.
